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needed to increase the cure rate. In vitro experiments show
strong antiviral effects of ﬂuvastatin against HCV.
Aim of the study: To asses the clinical outcome of ﬂuvastatin
addition to the standard regimen for treatment of chronic
HCV in Egypt.
Subjects and Methods: The study included 80 patients
with chronic hepatitis C virus infection fulﬁlled clinical,
laboratory and histo-pathological criteria to be ready for
interferon therapy, divided into two groups: Group I (n = 40)
received standard treatment for HCV (pegylated interferon
and ribavirin) and group II (n = 40) received standard
treatment plus ﬂuvastatin (80mg/daily). Before and after
6 months of treatment liver function tests and HCV-RNA
were evaluated.
Results: Addition of ﬂuvastatin to the standard HCV
treatment (pegylated interferon and ribavirin) signiﬁcantly
increased SVR from (55% to 62.5%; P< 0.01) and signiﬁcantly
decreased viral load in relapser patients (P< 0.001). No
signiﬁcant differences and correlations were found between
serum levels of LDL-cholesterol and viral load before and
after treatment in both groups.
Conclusion: Fluvastatin can be used to increase SVR when
added to standard treatment (pegylated interferon and
ribavirin) of chronic HCV.
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Background: We have found 70% response rate in Pakistan
for Genotype-3a patients with combinationtherapy of
interferon and ribavirin. There is need to individualize the
treatment to minimize the side effects.
Methods: For the current study ﬁve G3 patients,
nonresponder of 24 weeks interferon-alpha-2b plus ribivirin
therapy, withalmost equal levels of viremia (1.8×107
IU/ml) at the end of treatmentwere selected. Mean
viral load at week 36 was 2.6×106 IU/ml, atweek 48
raised to 2.0×107 IU/ml. All samples were quantiﬁed on
RotorGene3000™. Interferon sensitivity-determining region
(ISDR) innon-structural region-5A was studied to link any
genetic changes in virus genomewith therapy esistance.
ISDR was ampliﬁed using genotype 3aspeciﬁc ISDR primers
followed by sequencing and bioinformatics tools.
Result: A157bp ISDR product corresponding to 52 aminoacid
protein, when compared with responderHCV patient naïve
genome [Table 1], eight amino acid mutations were
detected includingdeletions and substitutions affecting the
molecular weight of protein. Gly, Trp, Pro, Leu. His,
Thr were substituted by Arg, Gln, Ala, Pro, Pro, Ala
respectively.
Conclusion: Mutations in ISDR region may have role in
virus-resistance and high viremia, inﬂuencingthe therapy
response. Screening will help in deciding treatment plan
makingit cost-effective.
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Objectives: Our aim was to identify the prevalence of
hepatitis C virus (HCV) genotype and investigate genetic
mutation of HCV 5′ non-coding region (5′NCR) sequences in
Shandong province of China.
Methods: Serum samples from 118 chronic hepatitis C
patients hospitalized in Jinan Infectious Disease hospital
were collected. Serum samples were ampliﬁed from 5′NCR
by RT-PCR and PCR products were sequenced by Sangon
Biotech (Shanghai) Co., Ltd. Sequences of 5′NCR of the
patients were compared with reference HCV strains from
Genebank and phylogenetic tree analysis was performed.
Results: The cases among genotype 1b, 2a, 1a, 3a, 3b, 6a
were 65 (55.1%), 45 (38.1%), 2, 1, 2 and 3, respectively.
Sequences of 5′NCR in 42 genotype 1b patients were
identical. Compared to reference HCV 1b strains, 23
genotype 1b patients have 1 2 bases mutation with two
characteristic nucleotide mutation sites (120 C-T and 204
C-T). The homology of 5′NCR among genotype 2a patients
was 97.8%-100% with characteristic nucleotide mutation
sites (site 222 C-T and 247 C-T). The homology of genotype
1a, 3a, 3b and 6a with the same genotype HCV stains from
Genebank was high, only with 1 3 bases mutation.
Conclusions: The predominant genotype of chronic
hepatitis C patients in Shandong province is 1b, followed
by 2a and a small amount of 1a, 3a, 3b, 6a. Genotype 3a
and 6a are not reported before. Sequence of HCV 5′NCR is
highly conservative and accords to HCV strains worldwide.
Both genotype 1b and 2a have characteristic nucleotide
mutations.
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Background: Development of HCV infection is typically
followed by chronic hepatitis C (CHC) in most patients,
while spontaneous HCV viral clearance (SVC) occurs in only
a minority of subjects. With the development of techniques
for direct detection of the HCV virus (RNA or core protein), it
is expected that HCV infectious status can be evaluated bet-
ter if the results of HCV antibodies and virus detection were
